PURPOSE: The interaction between grapefruit-containing beverages and immunosuppressants is not well defined in the literature. This study was conducted to investigate possible sources of grapefruit juice or grapefruit extract in common US-manufactured beverages. The goal was to identify those products that might serve as hidden sources of dietary grapefruit intake, increasing a transplant patient's risk for drug interactions. METHODS: A careful review of the ingredients of the 3 largest US beverage manufacturer's product lines was conducted through manufacturer correspondence, product labeling examination, and online nutrition database research. Focus was placed on citrus-flavored soft drinks, teas, and juice products and their impact on a patient's immunosuppressant regimens. RESULTS: Twenty-three beverages were identified that contained grapefruit. Five did not contain the word "grapefruit" in the product name. In addition to the confirmed grapefruit-containing products, 17 products were identified as possibly containing grapefruit juice or grapefruit extract. CONCLUSION: A greater emphasis should be placed upon properly educating patients regarding hidden sources of grapefruit in popular US beverages and the potential for food-drug interactions.
PURPOSE: The interaction between grapefruit-containing beverages and immunosuppressants is not well defined in the literature. This study was conducted to investigate possible sources of grapefruit juice or grapefruit extract in common US-manufactured beverages. The goal was to identify those products that might serve as hidden sources of dietary grapefruit intake, increasing a transplant patient's risk for drug interactions. METHODS: A careful review of the ingredients of the 3 largest US beverage manufacturer's product lines was conducted through manufacturer correspondence, product labeling examination, and online nutrition database research. Focus was placed on citrus-flavored soft drinks, teas, and juice products and their impact on a patient's immunosuppressant regimens. RESULTS: Twenty-three beverages were identified that contained grapefruit. Five did not contain the word "grapefruit" in the product name. In addition to the confirmed grapefruit-containing products, 17 products were identified as possibly containing grapefruit juice or grapefruit extract. CONCLUSION: A greater emphasis should be placed upon properly educating patients regarding hidden sources of grapefruit in popular US beverages and the potential for food-drug interactions.
Entities:
Keywords:
drug interaction; grapefruit; immunosuppression
Authors: L J Brunner; M Y Munar; J Vallian; M Wolfson; D J Stennett; M M Meyer; W M Bennett Journal: Pharmacotherapy Date: 1998 Jan-Feb Impact factor: 4.705
Authors: A A Hollander; J van Rooij; G W Lentjes; F Arbouw; J B van Bree; R C Schoemaker; L A van Es; F J van der Woude; A F Cohen Journal: Clin Pharmacol Ther Date: 1995-03 Impact factor: 6.875
Authors: Mary F Paine; Wilbur W Widmer; Susan N Pusek; Kimberly L Beavers; Anne B Criss; Jennifer Snyder; Paul B Watkins Journal: Am J Clin Nutr Date: 2008-04 Impact factor: 7.045